title: In reply.
authors.affiliation: Laboratorio de Genética Molecular, Centro de Microbiologıa y Biologıa Celular, Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela; Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France.
authors.forename: Howard
authors.initials: H
authors.lastname: Takiff
authors.affiliation: Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France.
authors.forename: Amel-Kevin
authors.initials: AK
authors.lastname: Alame-Emane
authors.affiliation: Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France; Laboratoire de Bactériologie, Bichat-Claude Bernard Hospital, Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Pierre-Audigier
authors.affiliation: Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France; Emerging Bacterial Pathogens Laboratory, Institut Pasteur of Shanghai, Shanghai, China.
authors.forename: Brigitte
authors.initials: B
authors.lastname: Gicquel
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D024841:Fluoroquinolones / Q000627:therapeutic use*; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D011718:Pyrazinamide / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000995:Antitubercular Agents; D024841:Fluoroquinolones; D011718:Pyrazinamide; D012293:Rifampin